These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 37336427)

  • 21. (S)-norketamine and (2S,6S)-hydroxynorketamine exert potent antidepressant-like effects in a chronic corticosterone-induced mouse model of depression.
    Yokoyama R; Higuchi M; Tanabe W; Tsukada S; Naito M; Yamaguchi T; Chen L; Kasai A; Seiriki K; Nakazawa T; Nakagawa S; Hashimoto K; Hashimoto H; Ago Y
    Pharmacol Biochem Behav; 2020 Apr; 191():172876. PubMed ID: 32088360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lithium augmentation of ketamine increases insulin signaling and antidepressant-like active stress coping in a rodent model of treatment-resistant depression.
    Price JB; Yates CG; Morath BA; Van De Wakker SK; Yates NJ; Butters K; Frye MA; McGee SL; Tye SJ
    Transl Psychiatry; 2021 Nov; 11(1):598. PubMed ID: 34824208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuregulin signaling mediates the acute and sustained antidepressant effects of subanesthetic ketamine.
    Grieco SF; Qiao X; Johnston KG; Chen L; Nelson RR; Lai C; Holmes TC; Xu X
    Transl Psychiatry; 2021 Feb; 11(1):144. PubMed ID: 33627623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex Differences in the Temporal Neuromolecular and Synaptogenic Effects of the Rapid-acting Antidepressant Drug Ketamine in the Mouse Brain.
    Thelen C; Flaherty E; Saurine J; Sens J; Mohamed S; Pitychoutis PM
    Neuroscience; 2019 Feb; 398():182-192. PubMed ID: 30537521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increasing doses of ketamine curtail antidepressant responses and suppress associated synaptic signaling pathways.
    Kim JW; Monteggia LM
    Behav Brain Res; 2020 Feb; 380():112378. PubMed ID: 31760154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine.
    Liu RJ; Fuchikami M; Dwyer JM; Lepack AE; Duman RS; Aghajanian GK
    Neuropsychopharmacology; 2013 Oct; 38(11):2268-77. PubMed ID: 23680942
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrasynaptic CaMKIIα is involved in the antidepressant effects of ketamine by downregulating GluN2B receptors in an LPS-induced depression model.
    Tang XH; Zhang GF; Xu N; Duan GF; Jia M; Liu R; Zhou ZQ; Yang JJ
    J Neuroinflammation; 2020 Jun; 17(1):181. PubMed ID: 32522211
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine D2/D3 but not dopamine D1 receptors are involved in the rapid antidepressant-like effects of ketamine in the forced swim test.
    Li Y; Zhu ZR; Ou BC; Wang YQ; Tan ZB; Deng CM; Gao YY; Tang M; So JH; Mu YL; Zhang LQ
    Behav Brain Res; 2015 Feb; 279():100-5. PubMed ID: 25449845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ketamine may exert antidepressant effects via suppressing NLRP3 inflammasome to upregulate AMPA receptors.
    Li JM; Liu LL; Su WJ; Wang B; Zhang T; Zhang Y; Jiang CL
    Neuropharmacology; 2019 Mar; 146():149-153. PubMed ID: 30496753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms for the antidepressant-like effects of a low-dose ketamine treatment in a DFP-based rat model for Gulf War Illness.
    Ribeiro ACR; Zhu J; Kronfol MM; Jahr FM; Younis RM; Hawkins E; McClay JL; Deshpande LS
    Neurotoxicology; 2020 Sep; 80():52-59. PubMed ID: 32592718
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antidepressant-like effects of ketamine in a mouse model of serotonergic dysfunction.
    Wilson C; Li S; Hannan AJ; Renoir T
    Neuropharmacology; 2020 May; 168():107998. PubMed ID: 32061666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressant-like cognitive and behavioral effects of acute ketamine administration associated with plasticity in the ventral hippocampus to medial prefrontal cortex pathway.
    Jett JD; Boley AM; Girotti M; Shah A; Lodge DJ; Morilak DA
    Psychopharmacology (Berl); 2015 Sep; 232(17):3123-33. PubMed ID: 25986748
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential involvement of serotonergic signaling in ketamine's antidepressant actions: A critical review.
    du Jardin KG; Müller HK; Elfving B; Dale E; Wegener G; Sanchez C
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Nov; 71():27-38. PubMed ID: 27262695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ketamine's rapid antidepressant effects are mediated by Ca
    Zaytseva A; Bouckova E; Wiles MJ; Wustrau MH; Schmidt IG; Mendez-Vazquez H; Khatri L; Kim S
    Elife; 2023 Jun; 12():. PubMed ID: 37358072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
    Koike H; Chaki S
    Behav Brain Res; 2014 Sep; 271():111-5. PubMed ID: 24909673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of metabolism in (R)-ketamine's antidepressant actions in a chronic social defeat stress model.
    Zhang K; Fujita Y; Hashimoto K
    Sci Rep; 2018 Mar; 8(1):4007. PubMed ID: 29507385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of group II metabotropic glutamate receptors in ketamine's antidepressant actions.
    Onisiforou A; Georgiou P; Zanos P
    Pharmacol Biochem Behav; 2023 Feb; 223():173531. PubMed ID: 36841543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-administration of cannabidiol and ketamine induces antidepressant-like effects devoid of hyperlocomotor side-effects.
    Sartim AG; Marques J; Silveira KM; Gobira PH; Guimarães FS; Wegener G; Joca SR
    Neuropharmacology; 2021 Sep; 195():108679. PubMed ID: 34157363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The N-methyl-D-aspartate receptor antagonist d-methadone acutely improves depressive-like behavior in the forced swim test performance of rats.
    Hanania T; Manfredi P; Inturrisi C; Vitolo OV
    Exp Clin Psychopharmacol; 2020 Apr; 28(2):196-201. PubMed ID: 31368772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.
    Niciu MJ; Henter ID; Luckenbaugh DA; Zarate CA; Charney DS
    Annu Rev Pharmacol Toxicol; 2014; 54():119-39. PubMed ID: 24392693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.